Regeneron's first-quarter results miss on lower Eylea demand Regeneron's first-quarter results missed Wall Street ... March 14, 2025 Bayer wins Brazil injunction in soy patent row with farmers ...

Brent Kendall is the Law Bureau Chief for The Wall Street Journal. A longtime legal affairs reporter, he has covered the Supreme Court and lower courts across the country, as well as the Justice ...

Although its stock has become a favorite on Wall Street thanks to success ... Various US officials from Congress and the US Patent & Trademark Office derided the Bayer decision, for example.

Pharma has so far been protected from Trump’s volatile trade war, although executives know the writing is on the wall ... Drugmakers Bayer, Johnson & Johnson and PhRMA were also among ...

Here are some of the largest recent moves: Wall Street analysts have issued reports ... including Regeneron’s agreements with Sanofi and Bayer (or their respective affiliated companies, as ...

Septal-wall thickness decreased by 8% ... Rossano disclosed relationships with Bayer, Bristol Myers Squibb, CRI Biotech, AskBio, Merck, and Biomarin. Adler disclosed being an employee of and ...

To be sure, many cancers are no hot coffee burn; it’s difficult at best to assign an indisputable exact cause to cancer.

Bayer has overturned a ruling that it brought discredit on the pharma industry. Accused of “warming the market” for a new Eylea indication, the German drugmaker successfully argued on appeal ...

Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) so far has paid about $10 billion to settle disputed claims, The Wall Street Journal reported, citing a spokesperson. Almost 67,000 cases were still pending at ...

CHICAGO (Reuters) - Bayer is exiting the seed treatment equipment business in the United States to help the company's ...

Leverkusen's Edmond Tapsoba, right, challenges for the ball with Augsburg's Elvis Rexhbecaj during the German Bundesliga soccer match between Bayer Leverkusen and FC Augsburg at the BayArena in ...